1-4 of 4
Xiaofeng Jiang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury

Available to Purchase
Yi Hu, Chun Yang, Tania Amorim, Mohsin Maqbool, Jenny Lin, Chen Li, Chuanfeng Fang, Li Xue, Ariel Kwart, Hua Fang, Mei Yin, Allison J. Janocha, Daisuke Tsuchimoto, Yusaku Nakabeppu, Xiaofeng Jiang, Alex Mejia-Garcia, Faiz Anwer, Jack Khouri, Xin Qi, Qing Y. Zheng, Jennifer S. Yu, Shan Yan, Thomas LaFramboise, Kenneth C. Anderson, Leal C. Herlitz, Nikhil C. Munshi, Jianhong Lin, Jianjun Zhao
Journal: Cancer Research
Cancer Res (2021) 81 (3): 713–723.
https://doi.org/10.1158/0008-5472.CAN-20-1010
Published: 01 February 2021
View articletitled, Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury
Open the PDF for Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury in another window
Includes: Supplementary data
Journal Articles

Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma

Available to Purchase
Yi Hu, Huimin Liu, Chuanfeng Fang, Chen Li, Fjorela Xhyliu, Hayley Dysert, Juraj Bodo, Gabriel Habermehl, Benjamin E. Russell, Wenjun Li, Marcia Chappell, Xiaofeng Jiang, Sarah L. Ondrejka, Eric D. Hsi, Jaroslaw P. Maciejewski, Qing Yi, Kenneth C. Anderson, Nikhil C. Munshi, Geyou Ao, Jason N. Valent, Jianhong Lin, Jianjun Zhao
Journal: Cancer Research
Cancer Res (2020) 80 (10): 2031–2044.
https://doi.org/10.1158/0008-5472.CAN-19-1077
Published: 15 May 2020
View articletitled, Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma
Open the PDF for Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Hyporesponsiveness to Natural Killer T-Cell Ligand α-Galactosylceramide in Cancer-Bearing State Mediated by CD11b+ Gr-1+ Cells Producing Nitric Oxide

Free
Kazuhiko Yanagisawa, Mark A. Exley, Xiaofeng Jiang, Nobuhiro Ohkochi, Masaru Taniguchi, Ken-ichiro Seino
Journal: Cancer Research
Cancer Res (2006) 66 (23): 11441–11446.
https://doi.org/10.1158/0008-5472.CAN-06-0944
Published: 04 December 2006
View articletitled, Hyporesponsiveness to Natural Killer T-Cell Ligand α-Galactosylceramide in Cancer-Bearing State Mediated by CD11b+ Gr-1+ Cells Producing Nitric Oxide
Open the PDF for Hyporesponsiveness to Natural Killer T-Cell Ligand α-Galactosylceramide in Cancer-Bearing State Mediated by CD11b+ Gr-1+ Cells Producing Nitric Oxide in another window
Journal Articles

The Tip60 histone acetyltransferase is essential for the acetylation and activation of the ATM protein kinase

Free
Brendan D. Price, Yingli Sun, Xiaofeng Jiang, Norvin Fernandes
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 545.
Published: 15 April 2006
View articletitled, The Tip60 histone acetyltransferase is essential for the acetylation and activation of the ATM protein kinase